
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Insulin resistance is a relatively common finding in chronic HIV infection and its treatment. The cycle of insulin resistance affects not only blood sugars and glucose tolerance but also fat metabolism and fat deposits. Thus, insulin resistance has been the topic of a lot of interest for treatment of the chronic ills associated with changes in glucose and fat metabolism. After discouraging results from previous studies on the insulin-sensitizing drugs rosiglitazone and metformin to improve the fat changes seen in chronic HIV infection, especially with a history of stavudine use, there is some encouraging news on the potential for these therapies to improve insulin sensitivity. While the medications may be used to improve blood sugar control for patients with diabetes, they both have interesting effects on fat metabolism and accumulation. Both medications can improve insulin sensitivity. However, they have somewhat different effects on lipodystrophy because they target different aspects of fat metabolism. [See the accompanying comparison of effects below.] Metformin works primarily in the liver to reduce the production of fat, while rosiglitazone works more in the peripheral areas of the body to improve the deposits of fat in subcutaneous areas (the pinchable kind). Because of this, metformin might contribute to the reduction of visceral fat accumulation (bellies and other central fat deposits) and rosiglitazone (and pioglitazone) may potentially improve fat deposits to bring back those lovely body shapes in the legs and arms. We might even see some future studies on the effect of fat maintenance in the face. On the topic of glitazones, a study of pioglitazone treatment showed improvement in limb fat that was considered significant in participants who were not using stavudine, which seems to have a limiting effect on the potential for glitazone therapy to reverse fat losses. However, on the upside, patients using pioglitazone didn't see any real further losses of fat, which suggests that its prevention potential might be worthy of investigation. It would be nice to think that all is beneficial, but we know better at this point than to expect only good things with as much experience as we have all had with multiple medications over long periods of time. Metformin may lower the 'bad' LDL cholesterol and raise the 'good' HDL cholesterol somewhat, while rosiglitazone may increase LDL. Metformin use has its downsides, such as the small potential for lactic acidosis. Patients taking metformin did not see benefit in gaining limb fat and may have even experienced continued losses. Varying results in the ability of metformin to reduce visceral fat volume suggests that its best use will be in cases of significant insulin resistance with a good amount of limb fat at baseline. The glitazones can be used without significant insulin resistance but should be watched for their contributions to changing blood-fat levels that may contribute to risk for heart disease. There are some limitations, and as you can imagine, there's need for more study in this area. Studies on these medications have involved relatively small numbers and were short in duration. It may take some time for each of these medications to show results that you can see in the mirror. Meanwhile, as you look over the options presented by this latest round of hopeful research with your health care team, it is a good time to renew your vow to take a look at your diet and exercise options to control the effects of insulin resistance. The benefits could be even better than expected if you start your own campaign to improve insulin resistance by combining any medication efforts with diet and exercise. Drug Effects on the BodyMetformin Weight: Lowers it Body mass index: Lowers it Waist circumference: Lowers it Subcutaneous fat mass: Lowers it Visceral fat mass: Lowers it LDL cholesterol: Lowers it HDL cholesterol: Increases it Rosiglitazone Weight: Increases it Body mass index: Increases it Waist circumference: No significant change Subcutaneous fat mass: Increases it Visceral fat mass: No significant change LDL cholesterol: Increases it HDL cholesterol: Increases it Fields-Gardner is the director of services for the HIV nutrition company Cutting Edge and is a member of the International AIDS Society and the American Dietetic Association's Dietetic Practice Group on HIV and AIDS. E-mail her at cade@hivplusmag.com.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Meet our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM